- Novartis Venture Fund participated in 9 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $292,982,051 (averaging $32,553,561 per round).
- Effector Therapeutics: Venture capital (Series C) ($38.6M)
- NeuroVia: Venture capital (Series A) ($14M)
- Neurovia: Venture capital (Series A) ($14M)
- Morgenthaler Ventures
- Consort Medical
- SR One
Want to see the complete list?